GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Alcon Inc.
Alcon is a global leader in vision care, from surgical equipment to contact lenses. The company's stock is a bet on demographics: an aging population and a growing middle class worldwide require vision correction, providing the company with stable demand.
Share prices of companies in the market segment - Pharma eyes
Alcon, a spinoff from Novartis, is a global leader in ophthalmology, operating in the surgical equipment and contact lens segments. We classify it as part of the Pharma Eyes sector, and the chart below reflects the overall dynamics of this segment, driven by an aging population.
Broad Market Index - GURU.Markets
Alcon is a global leader in ophthalmology, producing surgical equipment, contact lenses, and eye care products. It is a key component of the GURU.Markets index. The chart below depicts the market. See how demographic trends are impacting Alcon's business.
Change in the price of a company, segment, and market as a whole per day
ALC - Daily change in the company's share price Alcon Inc.
Alcon is a global leader in ophthalmology, producing surgical equipment and eye care products such as contact lenses. Its daily price change is a measure of volatility in the medical technology sector. This metric is important for analytical formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma eyes
Alcon Inc. is a global leader in ophthalmology. This chart shows the average daily volatility of the MedTech sector. Comparing it to ALC's performance helps understand how its diversification between surgical equipment and contact lenses makes its business stable.
Daily change in the price of a broad market stock, index - GURU.Markets
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess Alcon's response to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Alcon Inc.
Alcon is a global leader in eye care products, from contact lenses to surgical equipment. Its year-over-year growth reflects stable demand driven by demographic trends and the need for vision correction.
Annual dynamics of market capitalization of the market segment - Pharma eyes
Alcon Inc., a spinoff from Novartis, is a global leader in ophthalmology, producing contact lenses and surgical equipment. An aging population and growing need for vision correction are creating strong demand for its products. The chart below shows how its leadership in this niche is driving steady growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Alcon is a global leader in ophthalmology, producing eye surgery equipment and contact lenses. The company's growth is fueled by an aging population and the growing need for vision correction. This non-cyclical trend in healthcare ensures Alcon's stable growth.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Alcon Inc.
Alcon Inc.'s (ALC) Perf_Month_Co market capitalization dynamics reflect operating cycles driven by demand for its surgical equipment and contact lenses. Monthly fluctuations in the graph are driven by the pace of ophthalmological surgeries, the success of new product launches, and the competitive environment in the vision sector.
Monthly dynamics of market capitalization of the market segment - Pharma eyes
This chart shows the dynamics of the medical technology sector, particularly in ophthalmology. For Alcon, a global leader in this field, this provides context. Demographic trends (an aging population) and stable demand for its surgical equipment and contact lenses are supporting the growth of the entire sector.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Alcon Inc. is a global leader in ophthalmology, producing surgical equipment and contact lenses. Demand for its products is driven by demographic trends (an aging population) and medical needs. A broad market chart shows how stable and predictable demand for vision care has made Alcon shares immune to general economic downturns.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Alcon Inc.
Alcon, a global leader in ophthalmology, shares weekly reflect demographic trends of an aging population and demand for vision improvement. Price movements reflect sales of contact lenses, cataract surgery equipment, and eye care innovations.
Weekly dynamics of market capitalization of the market segment - Pharma eyes
Ophthalmology is a sector that is growing alongside an aging population. Weekly trends across the industry reflect the demand for treatment of cataracts, glaucoma, and other age-related eye diseases. The chart illustrates this overall demographic trend, which underscores Alcon's leadership.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Alcon is a global leader in eye care products, from contact lenses to surgical equipment. Demand for its products is driven by medical needs. The chart below shows how Alcon shares are a "defensive" medical stock, less susceptible to market turbulence.
Market capitalization of the company, segment and market as a whole
ALC - Market capitalization of the company Alcon Inc.
Alcon's market capitalization chart tells the story of a global leader in vision care, from contact lenses to surgical equipment. Its performance since its spinoff from Novartis reflects growing demand, fueled by an aging population and the spread of vision problems. Its growth reflects the market's appreciation of innovation and the strength of brands in ophthalmology.
ALC - Share of the company's market capitalization Alcon Inc. within the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products such as contact lenses and solutions. Its dominant market share reflects decades of innovation and the trust of physicians and patients. The chart shows the weight of this giant, focused on eye health.
Market capitalization of the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. The chart below shows the overall market capitalization of the eye care sector. Its robust growth reflects an aging population and the growing need for vision correction and treatment of eye diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
Alcon is a global leader in ophthalmology, producing everything from contact lenses to surgical equipment. Its market capitalization reflects the global trend toward vision care in a world with an aging population and increasing screen use. Its growth on the overall chart is an indicator of the importance of eye health in modern life.
Book value capitalization of the company, segment and market as a whole
ALC - Book value capitalization of the company Alcon Inc.
Alcon, a leader in ophthalmology, owes its book value to its high-tech contact lens manufacturing facilities, surgical equipment, and research centers. This is tangible, knowledge-intensive capital that restores people's sight. How has this innovative medical asset grown? The chart below shows the dynamics of its stable development.
ALC - Share of the company's book capitalization Alcon Inc. within the market segment - Pharma eyes
Alcon, a global leader in ophthalmology, manufactures lenses, equipment, and medications in its own high-tech factories. The chart shows the share of these unique manufacturing assets in the sector, reflecting the physical scale required to protect and restore vision.
Market segment balance sheet capitalization - Pharma eyes
Manufacturing ophthalmic products on Alcon's scale is a capital-intensive business. Owning factories for surgical equipment and contact lenses makes it a heavyweight relative to the broader healthcare sector.
Book value of all companies included in the broad market index - GURU.Markets
Alcon's assets include high-tech factories producing ophthalmological products, from contact lenses and solutions to sophisticated surgical equipment for eye surgeries. Its book value reflects the production and scientific potential of this global leader in vision care. The chart shows its importance in the medical technology sector.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Alcon Inc.
Alcon, a global leader in ophthalmology, is valued at a premium to its manufacturing plants. Investors are paying for its strong brand, its innovations in surgical equipment and contact lenses, and its aging population, which ensures long-term demand.
Market to book capitalization ratio in a market segment - Pharma eyes
Alcon is a global ophthalmology leader, producing equipment and consumables for eye surgery, as well as contact lenses. Its value lies in innovation and a strong brand. The chart shows how the market values its technological leadership in the growing healthcare sector.
Market to book capitalization ratio for the market as a whole
Alcon is a global leader in ophthalmology, producing eye surgery equipment and contact lenses. The company's value lies in its technologies, patents, and the trust of physicians. This metric demonstrates the high valuation the market places on companies operating in the growing healthcare sector driven by an aging population.
Debts of the company, segment and market as a whole
ALC - Company debts Alcon Inc.
Alcon, a global ophthalmology leader, uses debt to fund research and development of new surgical instruments and contact lenses, as well as targeted acquisitions. This chart shows how the company, after spinning off from Novartis, is strategizing its financial strategy to maintain its technological leadership.
Market segment debts - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment, contact lenses, and eye care products. This sector is supported by demographic trends of an aging population. The chart shows how the company, spun off from Novartis, is managing its debt to fund innovation and marketing to strengthen its position in this growing market.
Market debt in general
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products (contact lenses and solutions). This market is supported by an aging population. This chart provides an opportunity to assess how Alcon, spun off from Novartis, manages its debt and funds innovation to maintain leadership in its specialized niche.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Alcon Inc.
Alcon is a global leader in ophthalmology, requiring continuous investment in research and development. This chart illustrates how the company balances its use of equity and debt to fund innovation and global expansion. It helps understand Alcon's financial strategy to maintain its technological leadership.
Market segment debt to market segment book capitalization - Pharma eyes
Alcon, a global ophthalmology leader, produces surgical equipment and vision care products (contact lenses and solutions). This chart compares the company's debt to the overall market capitalization of the pharmaceutical sector. It shows how the company, spun off from Novartis, is managing its balance sheet and funding innovation for the growing vision care market.
Debt to book value of all companies in the market
Alcon, a leader in ophthalmology, operates in the defensive healthcare sector. This chart compares the company's debt to the overall market capitalization. It helps understand how stable the company's financial policy, supported by demographic trends, is and how unaffected it is by short-term economic downturns.
P/E of the company, segment and market as a whole
P/E - Alcon Inc.
Alcon is a global leader in ophthalmology, producing contact lenses, solutions, and surgical equipment for the treatment of eye diseases. This chart shows how investors value its strong position in a growing market. This high valuation reflects an aging population and the growing need for vision correction.
P/E of the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, developing and manufacturing surgical equipment and consumer eye care products (such as contact lenses). This chart shows the average rating for the pharmaceutical sector, helping to understand how the market values Alcon's specialization and innovation in eye health.
P/E of the market as a whole
Alcon, spun off from Novartis, is a global leader in ophthalmology, producing contact lenses and surgical equipment. Demand for its products is driven by medical needs and an aging population. How isolated is its valuation from the general market cycles reflected in this chart, operating within the laws of the healthcare sector?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Alcon Inc.
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. The company's future profitability depends on an aging population and growing demand for vision correction. This chart shows market expectations regarding the development of ophthalmic technologies and increasing spending on eye care.
%20P%2FE%20Alcon%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Alcon-Inc.&v=1772547601324 "Chart of the company's future (projected) P/E Alcon Inc.")
Future (projected) P/E of the market segment - Pharma eyes
Alcon is a global ophthalmology leader, spun off from Novartis, producing surgical equipment for cataract and glaucoma treatment, as well as contact lenses and solutions. This chart shows how the market views Alcon's profitability prospects, reflecting expectations of increased demand for its products due to an aging population and the spread of vision problems.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-eyes&v=1772547601388 "Future (projected) P/E graph of the market segment - Pharma eyes")
Future (projected) P/E of the market as a whole
Alcon is a global leader in vision care products, including contact lenses and surgical equipment. The company's growth is fueled by an aging population and growing demand for vision correction. This overall forecast chart highlights the company's position in the non-cyclical healthcare sector.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772547601451 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Alcon Inc.
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. This chart shows how the company makes money by providing vision care. Profit growth is driven by an aging population, growing demand for cataract surgery, and innovations in contact lenses and solutions.
Profit of companies in the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products such as contact lenses and solutions. This chart shows profitability in the vision care sector. An aging population and the increasing prevalence of vision problems create long-term demand for Alcon products, ensuring sustainable growth.
Overall market profit
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products such as contact lenses. The surgical segment is dependent on hospital budgets, while the consumer segment is dependent on household spending. The overall economic situation, reflected in this chart, influences both of these components, although demand for vision care is generally stable.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Alcon Inc.
Alcon Inc. is a global leader in ophthalmology, producing surgical equipment and contact lenses. This chart shows analysts' expectations for future profits. The forecast is based on an aging population, which increases the number of cataract surgeries, and growing demand for vision correction products among younger generations.
%20profit%20of%20the%20company%20Alcon%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Alcon-Inc.&v=1772547601659 "Graph of future (projected) profit of the company Alcon Inc.")
Future (predicted) profit of companies in the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products such as contact lenses and solutions. The sector's profit projections, shown in this chart, highlight demand driven by an aging population. This allows us to assess how Alcon's innovations are helping it maintain its leadership in this steadily growing market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-eyes&v=1772547601901 "Graph of future (predicted) profits of companies in a market segment - Pharma eyes")
Future (predicted) profit of the market as a whole
Alcon is a global leader in vision care products, including contact lenses, surgical equipment, and ophthalmic medications. Procedures such as cataract surgery are often elective, and their volume increases during periods of economic stability, as reflected in this chart.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772547602011 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Alcon Inc.
Alcon is a global leader in ophthalmology, producing surgical equipment and vision care products such as contact lenses. This chart shows how highly investors value the company's revenue. This high valuation reflects the growing demand for vision correction driven by an aging population and the proliferation of digital devices.
P/S market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment for eye surgeries and consumer products such as contact lenses and lens care solutions. This chart shows the average market value for the sector, helping to understand the premium placed on Alcon's dominance and innovation in the vision care market.
P/S of the market as a whole
Alcon is a global ophthalmology leader spun off from Novartis. The company produces surgical equipment for eye surgeries, as well as contact lenses and lens care products. This chart provides context for understanding how investors view the vision care leader's revenue compared to the market average.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Alcon Inc.
Alcon is a global leader in ophthalmology, producing surgical equipment and vision care products (contact lenses). This chart shows how investors estimate its future earnings. This valuation is fueled by an aging population and growing demand for vision correction and eye disease treatment.
%20P%2FS%20Alcon%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Alcon-Inc.&v=1772547602118 "The graph of the company's future (projected) P/S Alcon Inc.")
Future (projected) P/S of the market segment - Pharma eyes
Alcon Inc. is a global ophthalmology leader, producing surgical equipment and vision care products, including contact lenses and eye drops. This chart compares the company's estimated future sales with other ophthalmology product manufacturers. It reflects investor expectations for an aging population and growing demand for vision correction.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-eyes&v=1772547602123 "Future (projected) P/S market segment graph - Pharma eyes")
Future (projected) P/S of the market as a whole
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. Demand for its products is driven by an aging population and the need for vision correction. This graph of overall market expectations is less important to Alcon than demographic trends and innovations, which ensure the company's stable long-term growth.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772547602287 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Alcon Inc.
Here's a graph of Alcon's revenue, a global leader in ophthalmology. The company's revenue is divided into two segments: surgical equipment and consumables for eye surgeries (e.g., cataract surgery) and contact lenses and lens care products. Revenue growth is driven by an aging population, increased access to eye care, and product line innovations.
Sales of companies in the market segment - Pharma eyes
Alcon is a global ophthalmology leader, spun off from Novartis. The company produces surgical equipment for eye surgeries, as well as contact lenses and lens care products. This chart shows revenue in the ophthalmic pharmaceuticals sector. It reflects the aging population and growing demand for vision correction and eye disease treatments, the core of Alcon's business.
Overall market sales
Alcon Inc. is a global leader in ophthalmology, producing surgical equipment and vision care products (contact lenses and solutions). Demand for its surgical products is stable, while demand for consumer products varies with income. This chart, reflecting overall wealth, shows people's ability to spend money on improving vision, such as purchasing more modern lenses.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Alcon Inc.
Alcon is a global vision care leader, producing surgical equipment, contact lenses, and lens care products. This revenue forecast chart reflects demographic trends, such as an aging population. The growth is driven by expectations of an increase in cataract surgeries and growing demand for contact lenses.
%20sales%20of%20the%20company%20Alcon%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Alcon-Inc.&v=1772547602554 "Schedule of future (projected) sales of the company Alcon Inc.")
Future (projected) sales of companies in the market segment - Pharma eyes
Alcon is a global leader in ophthalmology. Spun off from Novartis, the company produces surgical equipment for eye surgeries, as well as contact lenses and lens care products under the Dailies and Air Optix brands. This chart shows projected revenue for the ophthalmic pharmaceuticals sector, reflecting demand driven by an aging population and vision problems.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-eyes&v=1772547603049 "Schedule of future (projected) sales of companies in the market segment - Pharma eyes")
Future (projected) sales of the market as a whole
Alcon is a global ophthalmology leader, producing eye surgery equipment and contact lenses. Demand for surgical products is stable, while demand for contact lenses is driven by consumer spending. Overall economic growth, predicted by the market, supports purchasing power and the availability of advanced ophthalmological services.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772547603091 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Alcon Inc.
Alcon is a global leader in vision care, producing contact lenses, solutions, and surgical equipment for ophthalmology. This chart shows the profitability of a business driven by innovation and demographic trends (such as an aging population). Continued demand for vision correction products ensures the company's stable and efficient revenue.
Market segment marginality - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products (contact lenses and solutions). The company's success depends on the profitability of both the surgical and consumer segments. This chart shows the average profitability in the sector. It allows one to assess the extent to which innovation and a strong Alcon brand contribute to its leadership.
Market marginality as a whole
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. Demand for its products is driven primarily by medical needs and demographic trends (such as an aging population), rather than short-term economic fluctuations, as shown in this chart. This ensures the company's sustainable and predictable growth.
Employees in the company, segment and market as a whole
Number of employees in the company Alcon Inc.
Alcon is a global leader in vision care, offering a wide range of products from surgical equipment to contact lenses. This chart shows the size of its global team of scientists, engineers, and sales professionals working to create innovations that help people see better.
Share of the company's employees Alcon Inc. within the market segment - Pharma eyes
Alcon is a global leader in eye care, specializing in surgical products and contact lenses. The development and production of these precision medical devices requires a large, skilled workforce. This chart demonstrates its dominant position in the ophthalmology market, measuring its share of the specialized workforce in the medical device field.
Number of employees in the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, producing surgical equipment and consumer products such as contact lenses and solutions. This chart reflects global demographic trends, particularly the aging population, which is leading to an increase in cataract surgeries. The company's growth is driven by innovation and the continued demand for vision care products.
Number of employees in the market as a whole
Alcon is a global leader in ophthalmology. Its extensive R&D and manufacturing capabilities are driven by the needs of an aging population and technological breakthroughs in vision correction and treatment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Alcon Inc. (ALC)
Alcon is a global leader in ophthalmology, manufacturing equipment and consumables. This chart reflects the research-intensive nature of their business. The company's high value is built on patents for unique lenses, surgical systems, and medications, which ensures the high value of each employee's contribution, especially in R&D.
%20of%20the%20company%20Alcon%20Inc.%20(ALC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Alcon-Inc.-ALC&v=1772547603561 "Chart of market capitalization per employee (in thousands of dollars) of the company Alcon Inc. (ALC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma eyes
Alcon is a global leader in ophthalmology, manufacturing surgical equipment and contact lenses. It is an R&D-intensive medical device business. This metric, compared to the industry average, reflects how much the market values their innovation and strong market position per employee.
%20by%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-eyes&v=1772547603592 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma eyes")
Market capitalization per employee (in thousands of dollars) for the overall market
Alcon is a global leader in ophthalmology, producing equipment and consumables for eye surgery, as well as contact lenses. This indicator reflects the value of innovation and brand equity in the medical field. The company's high-tech products ensure high margins and physician loyalty, which translates into high employee ratings.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772547603662 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Alcon Inc. (ALC)
Alcon is a global leader in ophthalmology, spun off from Novartis. They produce surgical equipment for eye surgeries and contact lenses. This is high-tech medicine. This chart demonstrates the value of their R&D. High profit per employee is the result of high margins on both equipment and consumables.
%20Chart%20Alcon%20Inc.%20(ALC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Alcon-Inc.-ALC&v=1772547603704 "Company Profit Per Employee (in thousands of dollars) Chart Alcon Inc. (ALC)")
Profit per employee (in thousands of dollars) in the market segment - Pharma eyes
Alcon is a global leader in eye health (surgery, lenses), spun off from Novartis. This chart shows the benchmark for Pharma (Medtech). Average profit per employee is high here. It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from blades (surgical consumables, lens solutions).
%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-eyes&v=1772547603741 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma eyes")
Profit per employee (in thousands of dollars) for the market as a whole
Alcon is a global leader in ophthalmology, producing eye surgery equipment and contact lenses. The company's business is built on precision technology and innovation. This chart shows the high profit per employee generated by this company operating in a highly specialized and science-intensive field of medicine.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772547603767 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Alcon Inc. (ALC)
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses. This chart demonstrates the value of their specialized products. Their high revenue per employee reflects innovation, a strong brand, and the trust of physicians and consumers in the growing vision care sector.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Alcon-Inc.-ALC&v=1772547603822 "Sales chart per company employee Alcon Inc. (ALC)")
Sales per employee in the market segment - Pharma eyes
Alcon is a global leader in eye health, spun off from Novartis. They produce ophthalmic surgical equipment and contact lenses (Vision Care). This includes R&D and precision manufacturing. This chart shows the average revenue per employee for the sector. It helps assess the productivity of Alcon's R&D and commercial teams in this niche.
Sales per employee for the market as a whole
Alcon is a global ophthalmology leader spun off from Novartis. They produce surgical equipment for eye surgeries and consumer products (contact lenses and solutions). They operate under a "razor and blades" model. This metric reflects how their team generates revenue from high-tech equipment and renewable consumables.
Short shares by company, segment and market as a whole
Shares shorted by company Alcon Inc. (ALC)
Alcon, a global vision care leader spun off from Novartis, produces contact lenses and surgical equipment. This chart highlights bearish bets. Skeptics may fear that a slowing economy will force people to change their lenses less frequently or postpone elective eye surgeries (such as cataract surgery).
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Alcon-Inc.-ALC&v=1772547603937 "Short Shares Chart for the Company Alcon Inc. (ALC)")
Shares shorted by market segment - Pharma eyes
Alcon is a global ophthalmology leader spun off from Novartis. This metric reflects skepticism. "Short" Alcon is a bet that people will skimp on eye health. Investors may expect that a recession will cause patients to postpone elective surgeries (like lens replacements) or switch to cheaper contact lenses.
Shares shorted by the overall market
Alcon is a global leader in ophthalmology, producing both surgical equipment (such as for cataract surgery) and consumer products (contact lenses). This market anxiety indicator has had little impact on Alcon's surgical segment. The demand for eye surgery is driven by an aging population and is unaffected by economic cycles, providing the company with powerful protection.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Alcon Inc. (ALC)
Alcon, spun off from Novartis, is a leader in ophthalmology equipment and consumables. Growth depends on the volume of elective surgeries. This oscillator above 70 may reflect strong demand for cataract surgery. A level below 30 is associated with concerns about pressure on hospital budgets.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Alcon-Inc.-ALC&v=1772547604068 "RSI 14 indicator chart for the company's stock Alcon Inc. (ALC)")
RSI 14 Market Segment - Pharma eyes
Alcon (ALC) is a global leader in eye care. They produce ophthalmological surgical equipment and consumer products (contact lenses, eye drops). This metric measures the "temperature" of the sector. It helps us understand: is ALC overheated due to an aging population, or is the entire medical equipment sector overbought?
RSI 14 for the overall market
Alcon is a global leader in ophthalmology, producing surgical equipment and contact lenses (spinned off from Novartis). This chart shows overall investor sentiment. It helps determine whether ALC fluctuations are driven by general panic in the medtech sector (oversold) or euphoria, rather than demographic trends (aging population) and demand for vision correction.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ALC (Alcon Inc.)
Alcon is a global leader in ophthalmology. The company produces surgical equipment (for example, for cataract surgery) and contact lenses (Vision Care). This chart is a collective 12-month forecast from analysts. It reflects their expectations for eye surgery volume and demand for new types of contact lenses.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ALC-Alcon-Inc.&v=1772547604516 "A chart showing analyst consensus forecasts for the expected stock price. ALC (Alcon Inc.)")
The difference between the consensus estimate and the actual stock price ALC (Alcon Inc.)
Alcon (ALC) is a global leader in eye health, spun off from Novartis. They produce ophthalmic surgical equipment and contact lenses (Air Optix). This chart shows the vision assessment. It measures the gap between the price and the consensus forecast, reflecting the potential analysts see in the aging population and growing demand for vision correction.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ALC-Alcon-Inc.&v=1772547604532 "A chart showing the difference between the consensus forecast and the actual stock price. ALC (Alcon Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma eyes
Alcon is a global leader in eye health, producing surgical equipment (for cataract surgery) and contact lenses (Vision Care). This chart shows analysts' overall expectations for the MedTech sector. It reflects whether experts believe demand for ophthalmic surgery will increase due to an aging population.
Analysts' consensus forecast for the overall market share price
Alcon Inc. is a global ophthalmology leader spun off from Novartis. The company produces surgical equipment for eye surgeries and contact lenses. Demand for its products is driven by an aging population. This chart shows overall market sentiment. For Alcon, which operates in a protective but technology-driven sector, the general optimism of analysts is less important than demographic trends and innovation.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Alcon Inc.
Alcon is a global ophthalmology leader spun off from Novartis. Their business is divided into two parts: surgical equipment (machines and consumables for cataract surgeries) and contact lenses/solutions. This chart is an indicator of eye health. It reflects the demographic trend of an aging population (increasing cataract rates) and the stable demand for vision care products.
AKIMA Market Segment Index - Pharma eyes
Alcon is a global vision care leader (spinned off from Novartis); the company dominates two segments: surgical equipment (cataracts) and contact lenses/solutions. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Alcon's dual (surgery + lenses) business model differentiate it from the average competitor?
The AKIM Index for the overall market
Alcon is a global leader in vision care. Spun off from Novartis, the company produces ophthalmic surgical equipment and contact lenses. This chart, reflecting the market average, provides context. It helps assess how Alcon, whose business relies on elective surgeries (cataracts) and consumer spending on lenses, fits within the overall macroeconomic picture that impacts healthcare budgets.
